In pancreatic ductal adenocarcinoma (PDAC), chemokine axes, such as CXCL12‐CXCR4, are co‐opted by cancer‐associated fibroblasts (CAFs) for tumour growth and escape, and immunosuppression. This evidence concerns the gene CXCR4 and pancreatic ductal adenocarcinoma.